Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 57597.77 Crore) operating in Pharma...

Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 54796.98 Crore) operating in Pharma...

Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 45240.32 Crore) operating in Pharma...

Aurobindo Pharma Limited (ARBP) manufactures generic pharmaceuticals and active pharmaceuticalingredients.

Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 52371.19 Crore) operating in Pharma...

The brokerage raised the company’s EPS estimate for FY20/FY21 by 4.4 per cent/9 per cent, and expects a 9 per cent earnings CAGR over FY20–...

Credit Suisse has downgraded the stock to 'underperform' from 'neutral' with a target of Rs 345.

Aurobindo Pharma (ARBP) is a mid-sized Indian pharma company with one of the largest product portfolios in the US market.

Buy Aurobindo Pharma at a price target of Rs 920.

Buy Aurobindo Pharma Ltd. at a price target of Rs 836.

Buy Aurobindo Pharma Ltd. at a price target of Rs 690.

Buy Aurobindo Pharma Ltd. at a price target of Rs 909.0 .

Buy Aurobindo Pharma Ltd. at a price target of Rs 740.

If successful, this would be Aurobindo's largest ever acquisition, surpassing its $132.5 mn purchase of US vitamin maker Natrol Inc in 2014.

The fourth-quarter results have been disappointing and the next two do not look promising either according to IndiaNivesh.

The S&P BSE Small cap index has plunged over 5 per cent so far in the year. The correction since late April has made many stocks attractive.

The BSE Sensex has lost 3.55% so far in 2015. Contrast this with Chinese stocks, which have returned a stunning 52% gains.